ovel approaches in in-vitro fertilisation (IVF)
Not Applicable
Completed
- Conditions
- InfertilityPregnancy and Childbirth
- Registration Number
- ISRCTN35766970
- Lead Sponsor
- niversity Medical Centre Utrecht (UMCU) (The Netherlands)
- Brief Summary
2007 Results article in http://www.ncbi.nlm.nih.gov/pubmed/17336650 2007 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/17586832 Psychological impact 2008 Results article in https://pubmed.ncbi.nlm.nih.gov/18491824/ Patient discomfort, risks and costs (added 27/10/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 404
Inclusion Criteria
1. Patients with an indication for IVF or IVF/intracytoplasmic sperm injection (ICSI) based on tubal, male or unexplained infertility were recruited
2. Patients less than 38 years with a normal menstrual cycle (cycle length between period 25 - 35 days) and without severe obesity or underweight (body mass index [BMI] 18 - 28 kg/m^2) were eligible for the study
Exclusion Criteria
Does not comply with the above inclusion criteria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> The primary outcome parameters chosen for this study were:<br> 1. Pregnancy within one year of treatment after randomisation leading to term (greater than 37 weeks gestation) live birth<br> 2. Total costs per couple and child up to six weeks after expected delivery<br> 3. Patient discomfort/distress during IVF treatment<br>
- Secondary Outcome Measures
Name Time Method o secondary outcome measures